Lynne Terry | The Lund Report

Briefly: OHSU Opposes Trump Move Against Affirmative Action

Oregon Health & Science University is worried that the move will hurt diversity on its campus, which it has made one of its priorities.

Oregon Health & Science University has come out against a move by the administrati

By:

Lynne Terry

Updated: Third Case of Measles in Metro Area is Child in Clark County

Health officials are warning people who were at three stores on June 27 and 28 that they might have been exposed to the virus.

Updated: Friday, July 13, 2018 at 4:30 p.m.

By:

Lynne Terry

Briefly: Oregon Health Authority releases 2016 hospital data

The report shows that heart procedures are among the most expensive.

A new report from the Oregon Health Authority outlines a mixed picture on hospital payments.

By:

Lynne Terry

Confirmed Case of Measles in Portland Metro Area

Multnomah County is tracking a case of measles, identifying as many as 500 people who might have been exposed. At highest risk are 40 people, mostly infants.

Multnomah County is tracking a case of measles and has notified 500 people that they might have been exposed.

By:

Lynne Terry

Vancouver Trust Gives Money to Cascadia Behavioral Healthcare

M.J. Murdock Charitable Trust, established by the estate of the co-founder of Tektronix, gave the Oregon nonprofit $200,000 among nearly $15 million in grants.

The M.J. Murdock Charitable Trust in Vancouver has handed out nearly $15 million in grants to Oregon nonprofits, including Cascadia Behavioral Healthcare.

By:

Lynne Terry

OHSU Physician’s Emergency Department Tale Prompts Outpouring of Tearjerkers on Twitter

More than 415,000 people from around the globe have shared their own stories or reacted to the Tweet.

As an emergency room researcher, Dr. Esther Choo can spend years working on projects on healthcare policy.

By:

Lynne Terry

As Cancer Treatment Costs Soar, Young People Pay the Most

Led by a Portland-based researcher, a new study digs into the cost of care across different cancers and populations.

The rising cost of cancer care, with new drugs priced at $100,000 or more a year, worries policymakers and analysts concerned about the high healthcare bill in the United States.

By:

Lynne Terry

OHSU Researchers Find Some Costly, Recommended Cancer Treatments Lack Evidence

The scientists raise questions about the influence of the pharmaceutical industry on medical recommendations ultimately adopted by Medicare, Medicaid.

Recommendations for costly new cancer drugs with potentially harmful side effects are often based on flimsy evidence, a new study says.

By:

Lynne Terry